EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY 4.0

Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonists in dialysis patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis

Tian Li, Tong Li, Yujun Xu, Diona Gjermeni, Lukas Heger, Dirk Westermann, Christoph B Olivier

Clinical Research in Cardiology · 2026

DOI: 10.1007/s00392-025-02711-7 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Research in Cardiology, 2026. Verfasst von Tian Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Renal Dialysis, Vitamin K, Anticoagulants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Freiburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

For patients with atrial fibrillation (AF) and preserved renal function, direct oral anticoagulants (DOACs) are superior to vitamin K antagonists (VKAs) for stroke prevention. However, the evidence in patients with end-stage kidney disease (ESKD) on dialysis remains inconclusive. In this systematic review and meta-analysis, we aim to compare the efficacy and safety of DOACs and VKAs in dialysis patients with nonvalvular AF. Methods and results We conducted a systematic literature review of publications comparing DOACs and VKAs in dialysis patients with nonvalvular AF. Data of RCTs and cohort studies were synthesized separately. Outcomes were reported as risk ratios with 95% confidence intervals. Heterogeneity was assessed using I 2 statistics. Ten studies were included in this meta-analysis: 4 RCTs (DOACs, 269 patients; VKAs, 217) and 6 cohort studies (DOACs, 7039 patients; VKAs, 22,983). In RCTs, the risk for major bleeding was significantly lower with DOACs compared with VKAs (RR 0.64, 95% CI 0.42–0.99, I 2 = 0%). In cohort studies, DOAC was associated with a lower risk for all-cause death compared with VKAs; however, with high heterogeneity (RR 0.78, 95% CI 0.62–0.98, I 2 = 80%). No significant differences were found regarding ischemic stroke or systemic embolism and gastrointestinal bleeding.

Conclusion

In dialysis patients with nonvalvular AF, DOACs were associated with significantly reduced risk for major bleeding in RCTs and significantly reduced risk for all-cause death in cohort studies. These findings suggest that DOACs may provide a higher net clinical benefit compared with VKAs in dialysis patients. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationRenal DialysisVitamin KAnticoagulantsStrokeKidney Failure, ChronicHumansAdministration, OralTreatment Outcome

Stichwörter der Autor:innen

AnticoagulationAtrial fibrillationChronic kidney failureDialysisDirect oral anticoagulantVitamin K antagonist

Substanzen

Vitamin KAnticoagulants

Autor:innen und Institutionen

  • Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
  • Department of Cardiac Surgery, Heinrich-Heine-University Medical School, Duesseldorf, Germany.
  • Faculty of Medicine, Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich, Munich, Germany.
  • Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. christoph.olivier@uniklinik-freiburg.d…

Förderung

  • Universitätsklinikum Freiburg

Zitieren

APA

Li, T., Li, T., Xu, Y., Gjermeni, D., Heger, L., Westermann, D., & Olivier, C. B. (2026). Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonists in dialysis patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02711-7

Vancouver

Li T, Li T, Xu Y, Gjermeni D, Heger L, Westermann D, et al. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonists in dialysis patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-025-02711-7

BibTeX
@article{Li2026,
  author = {Li, Tian and Li, Tong and Xu, Yujun and Gjermeni, Diona and Heger, Lukas and Westermann, Dirk and Olivier, Christoph B},
  title = {Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonists in dialysis patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00392-025-02711-7}
}
Kostenlos starten →